Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does the metabolic activity of metastatic thyroid carcinoma correlate with prognosis?

Nature Clinical Practice Endocrinology & Metabolism volume 2, pages 488–489 (2006)Cite this article

boxed-textRobbins RJ et al. (2006) Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F] fluoro- 2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab 91: 498–505

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Surveillance Epidemiology and End Results (SEER) [http://seer.cancer.gov/csr/1975_2001] (accessed 10 July 2006)

  2. Sherman SI et al. (1998) Prospective multicenter study of thyroid carcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer 83: 1012–1021

    Article  CAS  Google Scholar 

  3. Dinneen F et al. (1995) Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades. J Clin Endocrinol Metab 80: 2041–2045

    CAS  PubMed  Google Scholar 

  4. Feine U et al. (1996) Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. J Nucl Med 37: 1468–1472

    CAS  PubMed  Google Scholar 

  5. Wang W et al. (2000) Prognostic value of [18F] fluorodeoxyglucose positron emission tomographic scanning in patients with thyroid cancer. J Clin Endocrinol Metab 85: 1107–1113

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. BR Haugen is the Mary Rossick Kern and Jerome H Kern Associate Professor of Medicine and Pathology at the University of Colorado at Denver and Health Sciences Center, Aurora, CO, USA

    Bryan R Haugen

Authors
  1. Bryan R Haugen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bryan R Haugen.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Haugen, B. Does the metabolic activity of metastatic thyroid carcinoma correlate with prognosis?. Nat Rev Endocrinol 2, 488–489 (2006). https://doi.org/10.1038/ncpendmet0269

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0269

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing